EXMceuticals (FRA:9OM1) COGS-to-Revenue : 0.00 (As of Mar. 2021)

View and export this data going back to 2015. Start your Free Trial

What is EXMceuticals COGS-to-Revenue?

EXMceuticals's Cost of Goods Sold for the three months ended in Mar. 2021 was €0.00 Mil. Its Revenue for the three months ended in Mar. 2021 was €0.00 Mil.

EXMceuticals's COGS to Revenue for the three months ended in Mar. 2021 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. EXMceuticals's Gross Margin % for the three months ended in Mar. 2021 was N/A%.

EXMceuticals COGS-to-Revenue Historical Data

The historical data trend for EXMceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals COGS-to-Revenue Chart

EXMceuticals Annual Data

Trend

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

COGS-to-Revenue

Get a 7-Day Free Trial

EXMceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

EXMceuticals COGS-to-Revenue Calculation

EXMceuticals's COGS to Revenue for the fiscal year that ended in Jun. 2020 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

EXMceuticals's COGS to Revenue for the quarter that ended in Mar. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

EXMceuticals (FRA:9OM1) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

EXMceuticals's Gross Margin % for the three months ended in Mar. 2021 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

EXMceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of EXMceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

EXMceuticals (FRA:9OM1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (FRA:9OM1) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9

Website

http://www.exmceuticals.com

EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (FRA:9OM1) Headlines

No Headlines